HallMark Contributes to 2024 NI AMR Poultry Survey – FSA Report Released
HallMark Supports AMR Surveillance in NI Poultry Retail – Latest FSA Findings Released
We are proud to share that HallMark Veterinary and Compliance Services played a key role in supporting the latest Food Standards Agency (FSA) antimicrobial resistance (AMR) surveillance study, now published on the FSA’s official website.
This important report, covering 600 fresh broiler (chicken) and turkey samples collected across Northern Ireland in 2024, was part of the UK’s mandatory anonymised reporting under EU Regulation 2020/1729, submitted to the EU in May 2025.
🔗 Read the full FSA report here
Key Findings at a Glance
12% prevalence of ESBL/AmpC E. coli among fresh raw poultry samples—in line with 2022 UK levels, and lower than most EU countries.
No resistance was found to last-line antibiotics such as colistin or carbapenems.
Risk to the public remains very low when following safe food handling and cooking practices.
Acknowledging the Team Behind the Data
We would like to extend our sincere thanks to:
Our dedicated HallMark surveyors, who successfully carried out sample collection across Northern Ireland.
The AFBI laboratory team, for their expertise in AMR analysis, data interpretation, and authorship of the report.
The FSA for their leadership and ongoing commitment to monitoring and reducing antimicrobial resistance in the food chain.
This project, part of the ongoing FS900189 contract, reflects the power of collaboration between government, science, and veterinary public health.
Proud to Advance Veterinary Public Health
At HallMark, we are committed to protecting public health by supporting evidence-based surveillance and ensuring the safe supply of food across the UK. Participating in projects like this highlights the vital role our profession plays in addressing AMR risks, enhancing transparency, and contributing to international reporting efforts.
We are proud to see the HallMark logo featured on this publication and even prouder of the team that made it possible.
Together, we’re helping build a safer, healthier future—one sample at a time.
